Clinical trials in Greece – page 61

Greece is actively involved in clinical research focused on oncology and hematological malignancies, with trials addressing a wide range of cancers. Studies encompass non-small cell lung cancer, breast cancer, multiple myeloma, lymphomas, and leukemias. Research efforts concentrate on evaluating novel immunotherapies, targeted therapies, and combination treatment regimens designed to improve patient outcomes and survival rates.

• Trials investigating advanced and metastatic solid tumors including lung, breast, colorectal, and gastric cancers
• Studies on hematological conditions such as acute myeloid leukemia, chronic lymphocytic leukemia, and myelodysplastic syndromes
• Research on novel immunotherapy approaches and targeted molecular therapies
• Evaluation of maintenance therapies following stem cell transplantation in multiple myeloma patients

These trials aim to advance precision medicine approaches, optimize treatment sequencing, and identify biomarkers that predict therapeutic response in various cancer types.

Clinical trials in Greece address cardiovascular diseases, including atherosclerotic cardiovascular disease, heart failure, atrial fibrillation, and acute myocardial infarction. Research focuses on novel anticoagulants, anti-inflammatory agents, and therapies targeting specific cardiac pathologies. Studies evaluate interventions to reduce cardiovascular events, improve cardiac function, and manage complications associated with cardiovascular conditions.

• Trials on heart failure with reduced, mildly reduced, or preserved ejection fraction
• Studies evaluating anticoagulation strategies in atrial fibrillation and post-acute coronary syndrome
• Research on novel therapies for hypertrophic cardiomyopathy and transthyretin amyloid cardiomyopathy
• Investigation of inflammatory pathway modulation in cardiovascular disease prevention

These studies seek to establish more effective prevention strategies and therapeutic interventions for patients at high cardiovascular risk.

Research in Greece encompasses a broad spectrum of autoimmune diseases and inflammatory conditions. Trials investigate rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, psoriasis, and multiple sclerosis. Studies evaluate biologic agents, small molecule inhibitors, and immunomodulatory therapies aimed at controlling disease activity, reducing inflammation, and improving quality of life for patients.

• Trials on Crohn's disease and ulcerative colitis assessing novel biologics and targeted therapies
• Studies evaluating treatments for systemic lupus erythematosus and lupus nephritis
• Research on psoriatic arthritis and moderate to severe plaque psoriasis
• Investigation of disease-modifying therapies for relapsing multiple sclerosis

The objective is to develop more effective, personalized treatment strategies that achieve disease remission and prevent long-term complications.

Clinical trials in Greece focus on respiratory diseases including chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, and pulmonary arterial hypertension. Research evaluates bronchodilators, anti-inflammatory agents, antifibrotic therapies, and targeted treatments for progressive pulmonary conditions. Studies aim to improve lung function, reduce exacerbations, and slow disease progression.

• Trials on COPD with focus on reducing exacerbations and improving quality of life
• Studies investigating treatments for severe asthma with type 2 inflammation
• Research on idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
• Evaluation of therapies for pulmonary arterial hypertension and interstitial lung diseases

These studies seek to address unmet medical needs in chronic respiratory diseases and improve patient outcomes through innovative therapeutic approaches.

Greek research sites participate in trials addressing neurological disorders such as Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia, and myasthenia gravis. Studies evaluate disease-modifying therapies, symptomatic treatments, and interventions targeting specific pathological mechanisms. Research focuses on slowing cognitive decline, managing neurological symptoms, and improving functional outcomes.

• Trials investigating treatments for mild cognitive impairment and Alzheimer's disease
• Studies on generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy
• Research evaluating therapies for frontotemporal dementia and related conditions
• Investigation of agitation and psychosis associated with Alzheimer's disease

The goal is to develop effective interventions that preserve cognitive function and enhance quality of life for patients with neurodegenerative conditions.

Clinical research in Greece addresses metabolic diseases including type 2 diabetes, obesity, dyslipidemia, and non-alcoholic steatohepatitis. Trials evaluate novel glucose-lowering agents, weight management therapies, lipid-modifying treatments, and interventions for liver disease. Studies aim to improve glycemic control, reduce cardiovascular risk, and manage metabolic complications.

• Trials on type 2 diabetes evaluating novel oral and injectable therapies
• Studies investigating treatments for obesity and overweight with cardiovascular risk
• Research on familial hypercholesterolemia and severe hypertriglyceridemia
• Evaluation of therapies for non-alcoholic fatty liver disease and steatohepatitis

These studies focus on comprehensive metabolic risk management and prevention of long-term complications associated with metabolic disorders.

Research conducted in Greece includes trials on chronic kidney disease, IgA nephropathy, diabetic kidney disease, and related complications. Studies evaluate treatments aimed at slowing disease progression, managing proteinuria, and addressing complications such as anemia and hyperkalemia. Research focuses on novel therapeutic approaches targeting specific disease mechanisms.

• Trials investigating treatments for IgA nephropathy and C3 glomerulopathy
• Studies on chronic kidney disease with focus on cardiovascular and metabolic comorbidities
• Research evaluating therapies for anemia associated with chronic kidney disease
• Investigation of treatments for secondary hyperparathyroidism in dialysis patients

The objective is to preserve kidney function, reduce disease progression, and improve outcomes for patients with various forms of kidney disease.

Clinical trials in Greece address dermatological diseases including atopic dermatitis, psoriasis, hidradenitis suppurativa, and chronic spontaneous urticaria. Research evaluates biologic therapies, small molecule inhibitors, and topical treatments designed to control inflammation, reduce symptoms, and improve skin health. Studies aim to achieve disease clearance and enhance patient quality of life.

• Trials on moderate to severe atopic dermatitis assessing novel systemic therapies
• Studies investigating treatments for hidradenitis suppurativa and prurigo nodularis
• Research on plaque psoriasis and psoriatic arthritis with focus on skin and joint manifestations
• Evaluation of therapies for chronic spontaneous urticaria and cutaneous lupus erythematosus

These studies seek to provide effective long-term management options for patients with chronic inflammatory skin conditions.

Greek research sites participate in trials addressing infectious diseases including bacterial infections, viral infections, and fungal infections. Studies evaluate novel antibiotics, antiviral agents, and antifungal therapies for resistant pathogens and severe infections. Research also includes vaccine studies and prevention strategies for infectious diseases.

• Trials on complicated urinary tract infections and hospital-acquired pneumonia
• Studies investigating treatments for invasive fungal infections and candidemia
• Research on COVID-19 and post-acute COVID syndrome
• Evaluation of prevention strategies including vaccines for herpes zoster and respiratory syncytial virus

The focus is on developing effective treatments for multidrug-resistant infections and improving prevention strategies for vulnerable populations.

Clinical research in Greece encompasses hematological disorders such as hemophilia, paroxysmal nocturnal hemoglobinuria, thalassemia, and immune thrombocytopenia. Trials evaluate gene therapies, novel clotting factors, complement inhibitors, and treatments for inherited blood disorders. Studies aim to reduce bleeding episodes, manage transfusion dependence, and improve quality of life.

• Trials on hemophilia A and B evaluating gene therapy and extended half-life factors
• Studies investigating complement inhibitors for paroxysmal nocturnal hemoglobinuria
• Research on transfusion-dependent and non-transfusion-dependent thalassemia
• Evaluation of treatments for immune thrombocytopenia and autoimmune hemolytic anemia

These studies focus on transformative therapies that address the underlying causes of blood disorders and reduce treatment burden.

Greece participates in trials addressing rare diseases including Fabry disease, amyloidosis, epidermolysis bullosa, and Duchenne muscular dystrophy. Research evaluates enzyme replacement therapies, gene therapies, and targeted treatments for genetic and metabolic disorders. Studies aim to slow disease progression, manage symptoms, and improve functional outcomes for patients with rare conditions.

• Trials on transthyretin amyloidosis and light chain amyloidosis
• Studies investigating treatments for Duchenne muscular dystrophy and metachromatic leukodystrophy
• Research on recessive dystrophic epidermolysis bullosa and junctional epidermolysis bullosa
• Evaluation of therapies for hereditary angioedema and congenital hyperinsulinism

The objective is to provide effective treatments for conditions with limited therapeutic options and improve outcomes for rare disease patients.

Clinical trials in Greece address eye diseases including neovascular age-related macular degeneration, glaucoma, diabetic retinopathy, and thyroid eye disease. Studies evaluate anti-VEGF therapies, neuroprotective agents, and treatments for inflammatory and degenerative eye conditions. Research focuses on preserving vision, managing intraocular pressure, and reducing disease-related complications.

• Trials on neovascular age-related macular degeneration assessing novel anti-VEGF agents
• Studies investigating treatments for open-angle glaucoma and ocular hypertension
• Research on thyroid eye disease and vernal keratoconjunctivitis
• Evaluation of interventions for diabetic retinopathy and retinopathy of prematurity

These studies aim to develop effective therapies that prevent vision loss and improve quality of life for patients with ocular diseases.

Research in Greece includes trials on gastrointestinal disorders such as inflammatory bowel disease, functional dyspepsia, primary biliary cholangitis, and alcohol-related liver disease. Studies evaluate biologic therapies, small molecule inhibitors, and treatments targeting specific disease mechanisms. Research aims to achieve remission, manage symptoms, and prevent disease complications.

• Trials on ulcerative colitis and Crohn's disease evaluating induction and maintenance therapies
• Studies investigating treatments for primary biliary cholangitis and associated symptoms
• Research on non-alcoholic steatohepatitis and alcohol-related liver disease
• Evaluation of therapies for functional dyspepsia and erosive esophagitis

The focus is on improving disease management, achieving mucosal healing, and enhancing quality of life for patients with chronic gastrointestinal conditions.

Greece participates in pediatric clinical trials across various therapeutic areas including oncology, rare diseases, inflammatory conditions, and infectious diseases. Studies evaluate age-appropriate formulations, dosing regimens, and safety profiles of therapies in children and adolescents. Research focuses on conditions such as juvenile idiopathic arthritis, pediatric leukemias, and genetic disorders.

• Trials on childhood acute lymphoblastic leukemia and pediatric solid tumors
• Studies investigating treatments for systemic juvenile idiopathic arthritis
• Research on pediatric rare diseases including Duchenne muscular dystrophy and thalassemia
• Evaluation of vaccines and preventive therapies for pediatric populations

These studies aim to establish safe and effective treatments specifically tailored to the needs of pediatric patients.

Clinical trials in Greece address pain management and musculoskeletal conditions including acute low back pain, osteoarthritis, and rotator cuff tendinopathy. Research evaluates analgesic therapies, anti-inflammatory treatments, and interventions aimed at improving mobility and function. Studies focus on providing effective pain relief while minimizing adverse effects.

• Trials investigating treatments for acute moderate to severe low back pain
• Studies on moderate to severe rotator cuff tendinopathy
• Research evaluating novel analgesic approaches for musculoskeletal pain

The objective is to develop effective pain management strategies that improve patient function and quality of life.

Greece participates in trials involving hematopoietic stem cell transplantation, CAR T-cell therapy, and gene-modified cell therapies. Research evaluates prevention and treatment of complications such as graft-versus-host disease and transplant-associated thrombotic microangiopathy. Studies also include long-term follow-up of patients treated with gene therapies.

• Trials on prevention and management of chronic graft-versus-host disease
• Studies investigating CAR T-cell therapies for hematological malignancies
• Research on gene therapy approaches for inherited blood disorders

These studies aim to improve transplant outcomes and establish the long-term safety and efficacy of advanced cellular therapies.